Bradbury, C., Ward, J., Vyas, P., Russell, N., David, G., Hills, R., Burnett, A., Craddock, C., & Sylvie, F. (2016). Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation. 120(21).

Bradbury, C., et al. Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation. no. 21, 2016.

Bradbury, C, J Ward, P Vyas, N Russell, G David, R Hills, A Burnett, C Craddock, and F Sylvie. 2016. “Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation.” In . Vol. 120.